1. Home
  2. /
  3. Press Releases & Statements

Press Releases & Statements


Jul 12

2019

Killing Medicare Part D Rebate Rule a Huge Gift to Pharmacy Benefit Managers (PBMs)

Statement from Ted Okon, Executive Director, Community Oncology Alliance (COA): The Community Oncology Alliance (COA) is extremely disappointed that the Trump Administration is apparently withdrawing a proposed rule to eliminate rebates in Medicare Part D and Medicaid managed care. Killing this rule is a gift handed to the nation’s multi-billion-dollar middlemen corporations, the pharmacy benefit managers (PBMs).

Read more

Jul 11

2019

COA Statement on Proposed Radiation Oncology Alternative Payment Model

COA Supportive of CMMI Models that Advance Value-Based Care, but Remains Fundamentally Opposed to Mandatory Model Participation; In-Depth Analysis of Proposed Radiation Oncology Model Needed  Based on an initial review of the just announced Centers for Medicare & Medicaid Services’ (CMS) Radiation Oncology Alternative Payment Model, the Community Oncology Alliance (COA) has deep reservations

Read more

Jun 12

2019

Community Oncology Alliance Announces Ambitious Reform Model to Improve Cancer Care and Reduce Costs

Proposal to PTAC Demonstrates Continued Leadership of Community Oncology in Solving Complex Cancer Care Challenges The Community Oncology Alliance (COA) has developed an innovative and ambitious reform model to improve quality, reduce costs, and provide important additional cancer care services to patients. It is a detailed alternative payment model (APM) that includes bold proposals

Read more

May 23

2019

CMS Allows Middlemen to Force Patients to “Fail First” on Cancer Drugs While Paradoxically Keeping Cancer a Protected Class

Trump Administration Final Part D Rule Means All Medicare Patients with Cancer Will Face a More Dangerous Nightmare of Denials and Delays to Physician-Prescribed Treatments The Centers for Medicare & Medicaid Services (CMS) recently released its final rule for Medicare Part D that will maintain the status of cancer as a “protected class” in

Read more

May 15

2019

Community Oncology Alliance Launches Major National Campaign to Stop PBM Abuses and Highlight Patient Horror Stories

PBM Abuses Campaign Launched in Conjunction with Community Oncology Hill Day, Featuring Meetings Between Members of Congress and COA Advocates The Community Oncology Alliance is launching a major national campaign to highlight the negative impact of pharmacy benefit managers (PBMs) on patients with cancer. The “PBM Abuses” campaign will ensure that PBM middlemen abuse

Read more

Apr 9

2019

PBM Middlemen Continue to Dodge Responsibility for Patient Suffering and Rising Drug Prices

COA Applauds the Senate Finance Committee for PBM Hearing as Part of National Efforts to Shed Light on PBM Abuses and Lower Drug Prices More Investigation and Oversight Needed to Examine Adverse Impact of PBM Abuses on Patient Care Statement from Ted Okon, Executive Director, Community Oncology Alliance (COA): Today’s Senate Finance Committee hearing

Read more

Apr 5

2019

COA Hosts Cancer Care Teams, Advocates, and Stakeholders for Largest Community Oncology Conference Ever

Pharmacy Benefit Manager (PBM) Abuses and Patient Horror Stories Take Center Stage at Annual COA Conference Physicians, Administrators, Nurses, Pharmacists, Advocates, and Stakeholders Come Together to Share Latest Innovations in Cancer Care The most successful Community Oncology Alliance (COA) Community Oncology Conference ever, wrapped up today featuring a record-breaking nearly 1,600 community oncology physicians,

Read more

Mar 26

2019

Community Oncology Alliance Names Dr. Mark E. Thompson to Newly Created Medical Director for Public Policy Position

Experienced Community Oncologist Will Provide Valuable Guidance on Public Policy Related to Patient Access to Local, Affordable Care The Community Oncology Alliance (COA) announced today that Mark E. Thompson, MD, has been appointed to the newly created staff position of Medical Director for Public Policy. For over 30 years, Dr. Thompson was a practicing community

Read more

Mar 15

2019

COA Comments: CMS CAR-T Cell Therapy Proposed Coverage Determination

COA Submits Formal Comments to CMS on Proposed CAR-T Cell Therapy Coverage Determination Today the Community Oncology Alliance (COA) submitted a formal comment letter to the Centers for Medicare & Medicaid Services (CMS) regarding a proposed national coverage determination memo for CAR-T cell therapy. While COA is pleased that CMS is moving in the

Read more

Mar 6

2019

COA Statement on Departure of FDA Commissioner Scott Gottlieb, MD

“We are truly saddened by the departure of Scott Gottlieb, MD from the Food & Drug Administration (FDA).  The diversity of issues Commissioner Gottlieb tackled – including drug approvals, opioids, e-cigarettes/vaping, and more – and the modernization of the FDA were amazing.  During his brief tenure at the FDA, Dr. Gottlieb had to also deal

Read more